IP Library Assignment 026424/0925
Patent Assignment
Reel/Frame 026424/0925

Assignment of Assignor's Interest

Recorded: 2011-06-10 Pages: 8
Assignor
GILEAD PALO ALTO, INC.
Executed: 2011-05-11
Assignee
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404
Covered Properties (44)
N-Pyrazole A2A Adenosine Receptor Agonists
Patent: 6,403,567 →
Application: 09/338,185 →
C-Pyrazole A2A Receptor Agonists
Patent: 6,214,807 →
Application: 09/338,327 →
C-Pyrazole A2A Receptor Agonists
Patent: 6,855,818 →
Application: 09/812,176 →
Publication: US 2001/0018428
N-Pyrazole A2A Receptor Agonists
Patent: 6,642,210 →
Application: 10/018,446 →
C-Pyrazole A2A Receptor Agonists
Patent: 6,770,634 →
Application: 10/018,758 →
Method of identifying partial agonists of the A2A receptor
Application: 10/614,702 →
Publication: US 2004/0137533
Myocardial Perfusion Imaging Method
Patent: 7,683,037 →
Application: 10/629,368 →
Publication: US 2004/0064039
N-Pyrazole A2A Receptor Agonists
Patent: 7,183,264 →
Application: 10/652,378 →
Publication: US 2004/0038928
Myocardial Perfusion Imaging Methods and Compositions
Application: 10/766,403 →
Publication: US 2005/0020915
C-Pyrazole A2A Receptor Agonists
Patent: 7,109,180 →
Application: 10/813,535 →
Publication: US 2004/0198692
Myocardial Perfusion Imaging Method
Patent: 7,582,617 →
Application: 11/070,768 →
Publication: US 2005/0175535
N-Pyrazole A2A Receptor Agonists
Patent: 7,144,872 →
Application: 11/252,760 →
Publication: US 2006/0052332
Use of A2A Adenosine Receptor Agonists
Patent: 7,655,636 →
Application: 11/253,322 →
Publication: US 2006/0084625
C-Pyrazole A2A Receptor Agonists
Patent: 7,553,823 →
Application: 11/522,120 →
Publication: US 2007/0207978
N-Pyrazole A2A Receptor Agonists
Patent: 7,655,637 →
Application: 11/588,834 →
Publication: US 2007/0203090
Process for Preparing an A2A-Adenosine Receptor Agonist and Its Polymorphs
Patent: 7,732,595 →
Application: 11/701,699 →
Publication: US 2007/0265445
Process for Preparing an A2A-Adenosine Receptor Agonist and Its Polymorphs
Patent: 7,671,192 →
Application: 11/750,295 →
Publication: US 2007/0225247
Use of A2A Adenosine Receptor Agonists in the Treatment of Ischemia
Application: 11/766,964 →
Publication: US 2007/0299089
Methods and Compositions for Increasing Patent Tolerability During Myocardial Imaging Methods
Application: 11/848,743 →
Publication: US 2008/0213165
Methods for Myocardial Imaging in Patients Having a History of Pulmonary Disease
Application: 11/864,437 →
Publication: US 2008/0170990
Myocardial Perfusion Imaging
Application: 11/969,047 →
Publication: US 2008/0267861
Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods
Application: 12/163,099 →
Publication: US 2009/0081120
Methods of Coronary Imaging
Patent: 8,071,566 →
Application: 12/435,176 →
Publication: US 2009/0317331
C-Pyrazole A2A Receptor Agonists
Application: 12/491,791 →
Publication: US 2010/0081810
Method of Multidetector Computed Tomagraphy
Application: 12/569,643 →
Publication: US 2010/0086483
N-Pyrazole A2A Receptor Agonists
Application: 12/637,311 →
Publication: US 2010/0160620
Use of A2A Adenosine Receptor Agonists
Patent: 8,106,029 →
Application: 12/637,583 →
Publication: US 2010/0158797
Process for Preparing an A2A-Adenosine Receptor Agonist and Its Polymorphs
Patent: 7,956,179 →
Application: 12/687,077 →
Publication: US 2010/0179313
Myocardial Perfusion Imaging Method
Patent: 8,183,226 →
Application: 12/695,096 →
Publication: US 2010/0272645
Myocardial Perfusion Imaging Methods and Compositions
Patent: 8,133,879 →
Application: 12/749,328 →
Publication: US 2010/0183503
Process for Preparing an A2A-Adenosine Receptor Agonist and Its Polymorphs
Patent: 8,106,183 →
Application: 12/765,623 →
Publication: US 2010/0267953
N-Pyrazole A2A Receptor Agonists
Patent: 8,278,435 →
Application: 12/968,110 →
Publication: US 2011/0144320
Partial A2A adenosine receptor (ador) agonist
Application: 60/184,296 →
Low affinity A2A receptor agonists
Application: 60/219,876 →
Myocardial perfusion imaging agent
Application: 60/399,176 →
Low dosage myocardial perfusion imaging agent
Application: 60/399,177 →
Low dosage myocardial perfusion imaging agent
Application: 60/426,902 →
Myocardial perfusion imaging method
Application: 60/459,803 →
Use of A2A adenosine receptor agonists
Application: 60/620,577 →
Process for preparing an A2A-adenosine receptor agonist and its polymorphs
Application: 60/765,114 →
Process for preparing an A2A-adenosine receptor agonist and its polymorphs
Application: 60/801,857 →
Methods and compositions for increasing patient tolerability during myocardial imaging methods
Application: 60/841,842 →
Myocardial perfusion imaging
Application: 60/878,529 →
Method of Multidetector Computed Tomagraphy
Application: 61/101,043 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 21, 2006
From: BELARDINELLI, LUIZ; BLACKBURN, BRENT K.; GAO, ZHENHAI
To: CV THERAPEUTICS, INC.
Reel/Frame 018151/0484 →
Assignment of Assignor's Interest Oct 26, 2006
From: ZABLOCKI, JEFF A.; PALLE, VENKATA P.; ELZEIN, ELFAITH O.; BELARDINELLI, LUIZ
To: CV THERAPEUTICS, INC.
Reel/Frame 018438/0416 →
Assignment of Assignor's Interest Jul 16, 2007
From: GORDI, TOUFIGH; OLMSTED, ANN WALLS; BELARDINELLI, LUIZ; LIEU, HSIAO DEE
To: CV THERAPEUTICS, INC.
Reel/Frame 019561/0257 →
Assignment of Assignor's Interest Aug 3, 2007
From: ZABLOCKI, JEFF; ELZEIN, ELFATIH
To: CV THERAPEUTICS, INC.
Reel/Frame 019646/0780 →
Assignment of Assignor's Interest Mar 21, 2008
From: LIEU, HSIAO D.; BLACKBURN, BRENT; BELARDINELLI, LUIZ
To: CV THERAPEUTICS, INC.
Reel/Frame 020683/0764 →
Security Agreement Apr 16, 2008
From: CV THERAPEUTICS, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 020808/0823 →
Assignment of Assignor's Interest Apr 28, 2008
From: LIEU, HSIAO; BLACKBURN, BRENT; BELARDINELLI, LUIZ
To: CV THERAPEUTICS, INC.
Reel/Frame 020867/0642 →
Assignment of Assignor's Interest Mar 9, 2009
From: ZABLOCKI, JEFF A.; PALLE, VENKATA P.; ELZEIN, ELFATIH O.
To: CV THERAPEUTICS, INC.
Reel/Frame 022364/0422 →
Merger Oct 6, 2009
From: GILEAD PALO ALTO, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 023330/0648 →
Merger Dec 18, 2009
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023677/0983 →
Assignment of Assignor's Interest Jan 6, 2010
From: TPG-AXON ROYALTY TRUST
To: TPG-AXON LEX SUB-TRUST
Reel/Frame 023731/0916 →
Merger Jan 13, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023779/0821 →
Merger Jan 14, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023790/0759 →
Merger Jan 22, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023833/0461 →
Merger Jan 22, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023833/0361 →
Merger Jan 25, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023842/0893 →
Assignment of Assignor's Interest Mar 10, 2010
From: BELARDINELLI, LUIZ; DHALLA, ARVINDER
To: GILEAD PALO ALTO, INC.
Reel/Frame 024061/0251 →
Merger Mar 10, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024061/0255 →
Merger Aug 10, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024812/0366 →
Merger Aug 10, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 024812/0357 →
Assignment of Assignor's Interest Mar 9, 2011
From: ZABLOCKI, JEFF; ELZEIN, ELFATIH
To: GILEAD SCIENCES, INC.
Reel/Frame 025929/0602 →
Merger Jun 3, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026385/0001 →
Merger Jun 3, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026385/0014 →
Merger Jun 3, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026385/0050 →
Merger Jun 3, 2011
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 026385/0071 →